Cargando…
In Silico Designed Gain-of-Function Variants of Complement C2 Support Cytocidal Activity of Anticancer Monoclonal Antibodies
SIMPLE SUMMARY: The complement system can be exploited by anticancer antibody-based therapeutics. Activation of the classical complement pathway by the heavy chain of antibodies eventually leads to the lysis of target cells. However, overexpression of complement inhibitors by tumor cells limits the...
Autores principales: | Urban, Aleksandra, Majeranowski, Alan, Stasiłojć, Grzegorz, Koszałka, Patrycja, Felberg, Anna, Taszner, Michał, Zaucha, Jan M., Okrój, Marcin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909654/ https://www.ncbi.nlm.nih.gov/pubmed/35267578 http://dx.doi.org/10.3390/cancers14051270 |
Ejemplares similares
-
Mutations resulting in the formation of hyperactive complement convertases support cytocidal effect of anti-CD20 immunotherapeutics
por: Felberg, Anna, et al.
Publicado: (2019) -
Monitoring of the Complement System Status in Patients With B-Cell Malignancies Treated With Rituximab
por: Felberg, Anna, et al.
Publicado: (2020) -
Specific Activation of A(3), A(2A) and A(1) Adenosine Receptors in CD73-Knockout Mice Affects B16F10 Melanoma Growth, Neovascularization, Angiogenesis and Macrophage Infiltration
por: Koszałka, Patrycja, et al.
Publicado: (2016) -
Gain-of-Function Mutations R249C and S250C in Complement C2 Protein Increase C3 Deposition in the Presence of C-Reactive Protein
por: Urban, Aleksandra, et al.
Publicado: (2021) -
Substitutions at position 263 within the von Willebrand factor type A domain determine the functionality of complement C2 protein
por: Kuźniewska, Alicja, et al.
Publicado: (2022)